Ocular immune privilege
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The eye attempts to limit local immune and inflammatory responses to preserve vision. This phenomenon, known as ocular immune privilege, is mediated by a combination of local and systemic mechanisms. While immune privilege is believed to protect the eye from day-to-day inflammatory insults, it is not absolute and its mechanisms are still incompletely understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The small size, accessibility, confined structure, and immune-privileged status of the eye [74, 75], make it an ideal target for gene therapy”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“it has been shown that the eye exhibits physical barriers (e.g., blood-retina-barrier preventing free entry of systemic immune cells) as well as cell-bound and soluble immunosuppressive factors11,12.”
From Investigation of Cas9 Antibodies in the Human Eye (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · cited 1×
“that have recovered fromexperimental autoimmuneuveitis (EAU) contain regulatory activity, whose generation is dependent on the presence of eye [7-9].”
BackgroundOcular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
DeVoss, J., Hou, Y., Johannes, K., Lu, W., Liou, G. I., Rinn, J., Chang, H., Caspi, R. R., Fong, L., & Anderson, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061864 · Cited by 275
Self-citationSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218 · cited 1×
“It involvesmigration from the eye to the spleen of F4/80 antigen-presenting cells that interact with invariant natural killer T cells and B cells and culminates in elicitation of systemic regulatory immunity through induction of CD4 afferent and CD8 efferent Treg cells (reviewed in [4,6]).”
BackgroundOcular autoimmunity: the price of privilege?
Caspi, R. R. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00439.x · Cited by 162
Self-citationOcular Immunosuppressive Microenvironment
Taylor, A. W. (2007) · KARGER eBooks · doi:10.1159/000099255 · Cited by 160
Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells,
Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7525 · Cited by 126
Organ-Resident, Nonlymphoid Cells Suppress Proliferation of Autoimmune T-Helper Lymphocytes
Caspi, R. R., ROBERGE, F. G., & Nussenblatt, R. B. (1987) · Science · doi:10.1126/science.2956685 · Cited by 123
Self-citationSugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., & Mochizuki, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2846 · Cited by 99
Cited by
Items 101–200 of 269
Characterization of the secretory profile and exosomes of limbal stem cells in the canine species
Villatoro, A. J., Alcoholado, C., Martín‐Astorga, M. D. C., Rico-Llanos, G., Fernández, V., & Becerra, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244327 · Cited by 21
Takeuchi, M., Meguro, A., Nakamura, J., Chikagawa, R., Osada, R., Shibuya, E., Hasumi, Y., Yamada, N., Ishihara, M., & Mizuki, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-40565-z · Cited by 21
Seeing the Future: A Review of Ocular Therapy
Whalen, M., Akula, M., McNamee, S. M., DeAngelis, M. M., & Haider, N. B. (2024) · Bioengineering · doi:10.3390/bioengineering11020179 · Cited by 21
Jiang, J., Shen, W., He, Y., Liu, J., Ouyang, J., Zhang, C., & Hu, K. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112428 · Cited by 21
Prea, S. M., Chan, E. C., Dusting, G. J., Vingrys, A. J., Bui, B. V., & Liu, G. (2015) · Journal of Ophthalmology · doi:10.1155/2015/201726 · Cited by 25
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Yee, T., & Wert, K. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012375 · Cited by 22
Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface
Pennington, M. R., Saha, A., Painter, D. F., Gavazzi, C., Ismail, A. M., Zhou, X., Chodosh, J., & Rajaiya, J. (2019) · Microorganisms · doi:10.3390/microorganisms7090351 · Cited by 21
Denniston, A. K., Tomlins, P. J., Williams, G. P., Kottoor, S. H., Khan, I. J., Oswal, K. S., Salmon, M., Wallace, G. R., Rauz, S., Murray, P. I., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8802 · Cited by 19
Gruenert, A. K., Czugala, M., Mueller, C., Schmeer, M., Schleef, M., Kruse, F. E., & Fuchsluger, T. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152589 · Cited by 21
Anaphylaxis to polymyxin B–trimethoprim eye drops
Henao, M. P., & Ghaffari, G. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.01.014 · Cited by 18
Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
Chia, A. Y. T., Ang, G. W. X., Chan, A. S. Y., Chan, W. P. W., Chong, T. K. Y., & Leung, Y. Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.737256 · Cited by 19
The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
Manai, F., Govoni, S. M., & Amadio, M. (2022) · Cells · doi:10.3390/cells11244061 · Cited by 19
High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
Ultimo, A., Orzáez, M., Santos-Martínez, M. J., Martínez‐Máñez, R., Marcos, M. D., Sancenón, F., & Ruiz‐Hernández, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032753 · Cited by 18
Schuh, J. C. L. (2020) · Toxicologic Pathology · doi:10.1177/0192623320970448 · Cited by 17
Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies
Panikker, P., Roy, S., Ghosh, A., Poornachandra, B., & Ghosh, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.906482 · Cited by 19
Fortress, A. M., Miyagishima, K. J., Reed, A. A., Temple, S., Clegg, D., Tucker, B. A., Blenkinsop, T. A., Harb, G., Greenwell, T. N., Ludwig, T. E., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03282-y · Cited by 17
Unlocking the potential: advancements and applications of gene therapy in severe disorders
Ingle, R. G., Elossaily, G. M., Ansari, M. N., & Makhijani, S. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2516697 · Cited by 17
Chen, Y., Bounds, S. E., Ma, X., Karmoker, J. R., Liu, Y., Ma, J., & Cai, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311647120 · Cited by 16
Utilization of Nanoparticles for Treating Age-Related Macular Degeneration
Nikolaidou, A., Spyratou, E., Sandali, A., Gianni, T., Platoni, K., Lamprogiannis, L. P., & EFSTATHOPOULOS, E. P. (2025) · Pharmaceuticals · doi:10.3390/ph18020162 · Cited by 16
Pembrolizumab-induced optic neuropathy – a case report
Daetwyler, E., Zippelius, A., Meyer, P., & Laubli, H. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171981 · Cited by 16
Humic-acid-driven escape from eye parasites revealed by RNA-seq and target-specific metabarcoding
Noreikienė, K., Ozerov, M. Y., Ahmad, F., Kõiv, T., Kahar, S., Gross, R., Sepp, M., Pellizzone, A., Vesterinen, E. J., Kisand, V., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04306-9 · Cited by 17
MacLaren, R. E., Audo, I., Fischer, M. D., Huckfeldt, R. M., Lam, B. L., Pennesi, M. E., Sisk, R., Gow, J. A., Li, J., Zhu, K., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.017 · Cited by 15
The Complement System as a Therapeutic Target in Retinal Disease
Ong, J., Zarnegar, A., Selvam, A., Driban, M., & Chhablani, J. K. (2024) · Medicina · doi:10.3390/medicina60060945 · Cited by 17
Moody, K. J., Tinklepaugh, J., Obert, E., Grohn, K., DeRosa, J. R., Lumen, E., Moyer, B. S., Campbell, S., Wolfe, A. J., Sleeper, M. B., et al. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2146 · Cited by 17
Effects of intravitreal bevacizumab in Gram‐positive and Gram‐negative models of ocular inflammation
Lafreniere, J. D., Toguri, J. T., Gupta, R. R., Samad, A., O’Brien, D. M., Dickinson, J., Cruess, A. F., Kelly, M. E. M., & Seamone, M. E. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13453 · Cited by 15
Chuang, K., Ma, F., & Priore, L. V. D. (2017) · PubMed Central · Cited by 15
Eikenberry, J. L., Harris, A., Torabi, R., Lang, M., Denney, D., Vercellin, A. C. V., & Siesky, B. A. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120930688 · Cited by 17
The anterior chamber of the eye technology and its anatomical, optical, and immunological bases
Yang, S.-N., Shi, Y., & Berggren, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00024.2023 · Cited by 14
Chimal, R. Á., Vázquez-Vázquez, F. C., Serrano‐Bello, J., López-Barrios, K., Marichi-Rodríguez, F. J., & Álvarez-Pérez, M. A. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00254-5 · Cited by 14
Mody, A. A., Millar, J. C., & Clark, A. F. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.3 · Cited by 14
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease
Neo, S., Oliveira, M. M. S., Tong, L., Chen, Y., Chen, Z., Cismas, S., Burduli, N., Malmerfelt, A., Teo, J. K. H., Lam, K., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02917-5 · Cited by 14
Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma
Lu, J. E., Chang, J. R., Berry, J. L., In, G. K., & Zhang-Nunes, S. (2020) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000308 · Cited by 14
Application of CRISPR-Cas9 in eye disease
Wu, W., Tang, L., D'Amore, P. A., & Lei, H. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.06.007 · Cited by 16
Su, Y., Li, G., Xu, J., Zheng, J., Jiao, J., Zhang, J., Gu, X., Cai, Z., Luo, H., Zhou, L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021713 · Cited by 13
Mishra, A., Das, B., Nath, M., Iyer, S., Kesarwani, A., Bhattacharjee, J., Arindkar, S., Sahay, P., Jain, K., Sahu, P., et al. (2017) · Biology Open · doi:10.1242/bio.021618 · Cited by 14
Retina stem cells, hopes and obstacles
German, O. L., Vallese-Maurizi, H., Soto, T. B., Rotstein, N. P., & Politi, L. E. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1446 · Cited by 13
Meleis, A. M., Mahtabfar, A., Danish, S. F., & Foty, R. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186483 · Cited by 12
Attenuation of Experimental Autoimmune Uveitis in Lewis Rats by Betaine
Choi, Y., Jung, K., Kim, H. J., Chun, J., Ahn, M., Jee, Y., Ko, H. J., Moon, C., Matsuda, H., Tanaka, A., et al. (2021) · Experimental Neurobiology · doi:10.5607/en21011 · Cited by 12
Analysis of Parainflammation in Chronic Glaucoma Using Vitreous-OCT Imaging
Rodrigo, M. J., Subías, M., Montolío, A., Méndez-Martínez, S., Martínez, T., Arias, L., García-Herranz, D., Bravo‐Osuna, I., Garcia-Feijoo, J., Pablo, L. E., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121792 · Cited by 12
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
Schwartz, M. K., Likhite, S. B., Vetter, T. A., Baird, M., McGovern, V. L., Sierra-Delgado, J. A., Mendel, T., Burghes, A. H. M., & Meyer, K. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.05.016 · Cited by 11
Menon, A., & Vijayavenkataraman, S. (2022) · Artificial Organs · doi:10.1111/aor.14241 · Cited by 11
Clearing the light path: Proteoglycans and their important roles in the lens and cornea
Stepp, M. A., & Menko, A. S. (2024) · Proteoglycan Research · doi:10.1002/pgr2.20 · Cited by 10
Hypersensitivity toward bacterial stimuli in patients with age‐related macular degeneration
Chen, J., Han, B., Xu, S., Vu, H., Farrow, J. W., Rodman, C. L., Zhu, Y., & Wang, W.-Z. (2016) · Apmis · doi:10.1111/apm.12511 · Cited by 10
Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma
de Lange, M. J., Nell, R. J., & van der Velden, P. A. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00048-x · Cited by 12
Exploitation of enhanced prime editing for blocking aberrant angiogenesis
Huang, X., Wu, W., Qi, H., Yan, X., Dong, L., Yang, Y., Zhang, Q., Ma, G., Zhang, G., & Lei, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.006 · Cited by 10
Ajekiigbe, V. O., Agbo, C. E., Ogieuhi, I. J., Chidera Stanley Anthony, M., Adewole, O. A., Ahmed, B., Akingbola, A., Nwankwo, C. K., Kayode, A. T., Chima, U. E., et al. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03493-7 · Cited by 10
Naftulin, J. S., Penzi, L. R., Manatis-Lornell, A. J., Yasuda, M. R., Porter, M. L., Saavedra, A. P., & Senna, M. M. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0309-z · Cited by 10
Hwang, H. J., Lee, Y. W., Koh, K., Hwang, K. Y., Kwon, Y. A., Song, S. W., Kim, B. Y., & Kim, K. Y. (2020) · BMC Ophthalmology · doi:10.1186/s12886-020-01441-w · Cited by 10
Inflammatory markers of complete blood count in Fuchs uveitis syndrome
Şimşek, M., & Ozdal, P. C. (2020) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2020.10.016 · Cited by 10
Pathogenetic Mechanisms in Diabetic Retinopathy: From Molecules to Cells to Tissues
Biswas, S., & Chakrabarti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_9 · Cited by 10
Young, J. B., Keppel, T. R., Waas, M., Salmon, A. E., Buchberger, A. R., Skumatz, C. M. B., Gundry, R. L., & Kassem, I. S. (2020) · Molecular Omics · doi:10.1039/c9mo00169g · Cited by 9
Case Report: Management of Dead Intraocular Helminth Parasites in Asymptomatic Patients
Sah, R., Khatri, A., Sitaula, R. K., Kc, H., Rabaan, A. A., Tiwari, R., Dhama, K., Malik, Y. S., Donovan, S., Rodriguez-Morales, A. J., et al. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0218 · Cited by 9
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
Ameln, A. K., & Sprott, D. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02695-7 · Cited by 9
Zhang, H., Li, Y., Li, J., Li, X., & Li, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111405 · Cited by 9
Abadi, R. N. S., Abadi, Z., & Hooshmand, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11367-5 · Cited by 9
Sharma, R. K., Sharma, J., Khan, Z. K., Pattekar, A., Gupta, V., Bansal, R., Sharma, K., Aggarwal, A. N., Gupta, A., & Sachdeva, N. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32234-3 · Cited by 8
A new worm infiltrating the human cornea: A report of three cases
McBurney-Lin, S., Khorram, D., Gee, S. S., Hoberg, E. P., Klassen‐Fischer, M., & Neafie, R. C. (2018) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2018.01.013 · Cited by 9
Fujimoto, Y., Hikita, S., Takeda, K., Ozaki, K., Inoue, H., Takakuwa, H., Sonoda, K., & Ono, E. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25384 · Cited by 8
Lv, Y. X., Li, Q. Y., Duan, P., Zhang, M. F., Liu, B., Li, S., Zhao, T. T., Wang, H., Liu, Y., & Yin, Z. Q. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102424 · Cited by 9
The gut-retina axis: Uncovering the role of autoimmunity in glaucoma development
Yang, Z., Tian, D., Zhao, X., Luo, Y., & Chen, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35516 · Cited by 7
Non-viral gene therapy for Leber’s congenital amaurosis: progress and possibilities
Abdulsalam, L., Mordecai, J., & Ahmad, I. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2443387 · Cited by 7
Immunology of the canine eye in health and disease: a concise review
Dall’Ara, P., & Turin, L. (2019) · Veterinární Medicína · doi:10.17221/137/2017-vetmed · Cited by 8
Introduction: Overview of the Human Eye, Mammalian Retina, and the Retinoid Visual Cycle
Cioffi, C. L. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_94 · Cited by 14
Blyden, K., Thomas, J., Emami-Naeini, P., Fashina, T., Conrady, C. D., Albini, T. A., Carag, J. H., & Yeh, S. (2024) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000539 · Cited by 7
Somboonpatarakun, C., Intapan, P. M., Sanpool, O., Wongkham, C., & Maleewong, W. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0208 · Cited by 7
Challenges of cell therapies for retinal diseases
Monville, C., Morizur, L., & M’Barek, K. B. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.09.004 · Cited by 6
Lixi, F., Giannaccare, G., Salerno, G., Gagliardi, V., Pellegrino, A., & Vitiello, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14121160 · Cited by 8
Barle, E. L., Pfister, T., Fux, C., Röthlisberger, D., Jere, D., & Mahler, H. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.10.007 · Cited by 6
Harrell, C. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113528 · Cited by 6
Pigmentation level of human iPSC-derived RPE does not indicate a specific gene expression profile
Nakai, Y., Jin, J., Ogawa, T., Sakai, N., Maeda, A., Hironaka, K., Fukuda, M., Danno, H., Tanaka, Y., Hori, S., et al. (2023) · eLife · doi:10.7554/elife.92510 · Cited by 7
Odontogenic cell culture in PEGDA hydrogel scaffolds for use in tooth regeneration protocols.
Jaramillo, L., Briceño, I., & Durán, C. (2012) · PubMed · Cited by 5
Gene Therapy for Inherited Retinopathies: Update on Development Progress
Sun, S. Y., & Montezuma, S. R. (2018) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126418783934 · Cited by 6
Chitosan-Based Ocular Drug Delivery Systems
Natesan, S., Krishnaswami, V., Veedu, S. T., Mohanan, D. P., Kandasamy, R., & Palanichamy, R. (2019) · Springer eBooks · doi:10.1007/978-981-15-0263-7_4 · Cited by 5
Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics
Tufeu, M., Herkenne, C., & Kalia, Y. N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070903 · Cited by 4
Gong, X., & Hertle, R. W. (2024) · Life · doi:10.3390/life14111356 · Cited by 4
Environmental Microbes and Uveitis: Is Microbial Exposure Always Bad?
Massilamany, C., Gangaplara, A., & Reddy, J. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12297 · Cited by 4
The impact of mass spectrometry application to screen new proteomics biomarkers in Ophthalmology
Coronado, B. N. L., da Cunha, F. B. S., Nóbrega, O. D. T., & Martins, A. M. A. (2021) · International Ophthalmology · doi:10.1007/s10792-021-01807-z · Cited by 4
Challenges to Gene Editing Approaches in the Retina
Bonillo, M., Pfromm, J. K., & Fischer, M. D. (2022) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1757-9810 · Cited by 6
Geiger, T., Gerhards, H., Bjelica, B., Mackenthun, E., & Wollanke, B. (2022) · Veterinary Sciences · doi:10.3390/vetsci9080448 · Cited by 4
Emerging Gene Manipulation Strategies for the Treatment of Monogenic Eye Disease
Burgess, F. R., Hall, H. N., & Megaw, R. D. (2022) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000545 · Cited by 4
Consequences of a Rare Complement Factor H Variant for Age-Related Macular Degeneration in the Amish
Waksmunski, A. R., Miskimen, K. L. S., Song, Y. E., Grunin, M. A., Laux, R. A., Fuzzell, D., Fuzzell, S. L., Adams, L. D., Caywood, L. J., Prough, M. B., et al. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.9.8 · Cited by 4
Boonroumkaew, P., Sadaow, L., Kanchanangkul, N., Rodpai, R., Sanpool, O., Intapan, P. M., Blair, D., & Maleewong, W. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.06.006 · Cited by 3
Suppressive effect of aqueous humor on lipopolysaccharide-induced dendritic cell maturation
Wang, H.-F., Liu, J., Jiang, X., Lu, J., Li, X., & Song, X. (2011) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-011-0060-0 · Cited by 3
Calf melanin immunomodulates RPE cell attachment to extracellular matrix protein
Yacout, S. M., Elsawa, S. F., & Gaillard, E. R. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-4083-9 · Cited by 3
Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy
Zhou, J., Kamali, K., Lafreniere, J. D., & Lehmann, C. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0179 · Cited by 3
Gut microbiome dysbiosis in uveitis – mechanistic insights and emerging therapeutic strategies
Suresh, G., Nath, M., Tiwari, A., Halder, N., Chawla, R., & Velpandian, T. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111073 · Cited by 2
Diagnóstico y tratamiento inicial de la uveítis por médicos no oftalmólogos
Arango, O. T., la Torre, A. D., Pachón-Suárez, D. I., Salazar-Muñoz, J., & Parra-Morales, A. M. (2017) · Nova · doi:10.22490/24629448.2085 · Cited by 2
Stem Cells and Cellular Therapy
Friedlander, M., & Hinton, D. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00035-7 · Cited by 2
Quantifying the Role of Stochasticity in the Development of Autoimmune Disease
Nicholson, L. B., Blyuss, K. B., & Fatehi, F. (2020) · Cells · doi:10.3390/cells9040860 · Cited by 3
Inflammation in the Pathogenesis of Progressive Retinal Dystrophies
Hollingsworth, T. (2021) · Journal of Ophthalmic Research and Vision Care · doi:10.54289/jorvc2100103 · Cited by 3
The retina-specific basigin isoform does not induce IL-6 expression in mouse monocytes.
Solstad, A., Brown, J. M., & Ochrietor, J. D. (2023) · PubMed Central · Cited by 2
Aparicio-Alonso, M. (2022) · doi:10.22541/au.167166564.48950486/v1 · Cited by 2
The Phenotypical Characterization of Dual-Nature Hybrid Cells in Uveal Melanoma
Marcotte, E., Goyeneche, A. A., Abdouh, M., Burnier, J. V., & Burnier, M. N. (2024) · Cancers · doi:10.3390/cancers16183231 · Cited by 1
Liu, C., Yang, Q., Shen, Y., & Xu, M. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101428 · Cited by 1
Ophthalmologic Comorbidities in Alopecia Areata
Falla, P. M. G., Buendía‐Castaño, D., Hermosa‐Gelbard, Á., Burgos‐Blasco, B., Burgos‐Blasco, P., Vañó-Galván, S., & Saceda‐Corralo, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238409 · Cited by 1
Restoring Sight: The Journey of AIPL1 from Discovery to Therapy
Galieva, A., Karabelsky, A. V., & Egorov, A. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412066 · Cited by 1
Zhang, E., Bylund, R., Zhang, A., & Massop, D. (2025) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264251400700 · Cited by 1
Precision Is Not Enough: When Tools Outpace Translation in Ocular Gene Therapy
Elsayed, M. E. A. A., & MacLaren, R. E. (2026) · Genes · doi:10.3390/genes17030283 · Cited by 1
Lin, H., Wolfrum, P., Kempf, L. F., Wolters, D., Perumal, N., Korb, C. A., & Grus, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1824524 · Cited by 1
Metadata
- Authors
- Zhou, R., & Caspi, R. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caspi, Rachel R
- Venue
- F1000 Biology Reports
- Publisher
- H1 Connect
- Published
- 2010-01-18
- Volume
- 2
- ISSN
- 1757-594X (ISSN-L)
- DOI
- 10.3410/b2-3
- PMC
- PMC2948372
- OpenAlex
- W2132060134
- Cited by
- 259
- References
- 18
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 32 · 2023: 23 · 2022: 31 · 2021: 23 · 2020: 31 · 2019: 14 · 2018: 22 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000 Biology Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- ocular immune privilege, eye, inflammation, vision preservation, local immune regulation, ocular immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.